Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)
NEW YORK--(BUSINESS WIRE)--Jan 10, 2023--
Newman Ferrara LLP announced today that it has an ongoing investigation into actions taken by officers and directors of KBL Merger Corp. IV (“KBL”), a special purpose acquisition company (“SPAC”) in connection to its merger with 180 Life Sciences Corp. (NASDAQ:ATNF) (the “Merger”) that was completed on November 6, 2020.
If you did not exercise your redemption right prior to the completion of the Merger, you may contact Newman Ferrara attorneys Jeffrey Norton ( firstname.lastname@example.org ) or Benjamin Baker ( email@example.com ) to discuss this ongoing investigation.
Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230110005946/en/
CONTACT: Newman Ferrara LLP
Jeffrey M. Norton
1250 Broadway, 27thFl.
New York, NY 10001
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL
SOURCE: Newman Ferrara LLP
Copyright Business Wire 2023.
PUB: 01/10/2023 01:56 PM/DISC: 01/10/2023 01:55 PM